SpringerProtocols: Abstract: Viral Evaluation of Animal Cell Lines Used in Biotechnology

Viral Evaluation of Animal Cell Lines Used in Biotechnology

By: Alasdair J. Shepherd², Kenneth T. Smith²

Abstract

Full Text

Download PDF (97K)

Animal cell culture is being increasingly used for production of therapeutic reagents such as monoclonal antibodies, recombinant proteins, viral vaccines and replication incompetent viral vectors for gene therapy. Material derived from a variety of biological processes has been associated in the past with incidents involving the transmission of infectious agents, principally viruses (1). Thus, virological evaluation of animal cell substrates for use in the manufacture of biologicals is essential to ensure the safety of products for pharmaceutical use.

Affiliation(s): (2) Q-One Biotech Ltd., Glasgow, Scotland, UK

Book Title: Animal Cell Biotechnology: Methods and Protocols

Series: Methods in Biotechnology | Volume: 8 | Pub. Date: Feb-22-1999 | Page Range: 23-36 | DOI: 10.1385/0-89603-547-6:23

Subject: Biotechnology

References

Download References

1.	Petricciani, J. C. (1991) Regulatory philosophy and acceptibility of cells for the production of biologicals. Develop. Biol. Standard 75, 9–15.

2.	Medicines Control Agency. (1993). Rules and Guidance for Pharmaceutical Manufacturers, Her Majesty’s Stationery Office, London.

3.	Department of Health. (1987) The Good Laboratory Practice Regulations 1997. Department of Health, London.

4.	Center for Biologics Evaluation and Research. (1993) Points to Consider in The Characterization of Cell Lines Used to Produce Biologicals, US Food and Drug Administration, Washington, DC.

5.	Center for Biologics Evaluation and Research. (1994) Draft Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use, US Food and Drug Administration, Washington, DC.

6.	Committee for Proprietary Medicinal Products. (1995) Virus Validation Studies (Revised within CPMP BWP 3–4 July 1995) CPMP document CPMP/268/95, European Commission, Brussels.

7.	World Health Organisation. (1995) Draft Requirements for Cell Substrates Used for Biological Production. WHO Expert Committee on Biological Standardization 17–24 October 1995, Document BS/95. 1792, World Health Organization, Geneva.

8.	Committee for Proprietary Medicinal Products. (1995) Production and Quality Control of Monoclonal Antibodies. CPMP Approved 13 December 1994. Document III/5271/94, European Commission, Brussels.

9.	Committee for Proprietary Medicinal Products. (1995) Notes for Guidance on Quality of Biotechnological Products: Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin (CPMP/ICH/295/95) Step 2, Draft, 1,12,95, European Commission, Brussels.

10.	Committee for Veterinary Medicinal Products. (1995) The Rules Governing Medicinal Products in the European Union. Volume VII; Guidelines for Testing of Veterinary Medicinal Products, European Commission, Brussels.

11.	Center for Biologics Evaluation and Research. (1991) Points to Consider in the Human Somatic Cell Therapy and Gene Therapy, US Food and Drug Administration, Washington, DC.

12.	Center for Biologics Evaluation and Research. (1996) Addendum to the Points to Consider in the Human Somatic Cell Therapy and Gene Therapy, US Food and Drug Administration, Washington, DC.

13.	Kozak, C. A. and Ruscetti, S. (1992) Retroviruses in rodents, in The Retroviridae (Levy, J. A., ed.), Plenum, New York, vol. 1, pp. 405–481.

14.	Andrewes, C. A. (1989) Andrewes’ Viruses of Vertebrates, 5th ed. (Porterfield, J. S., eds.), Baillière Tindall, London.

15.	Mengeling, W. L. (1992) Porcine parvovirus, in Diseases of Swine, 7th ed. (Leman, A. D., Straw, B. E., Mengeling, W. L., D’Allaire, S., and Taylor, D. J., eds.), Wolfe Publishing Ltd. London, pp. 299–311.

16.	Croghan, D. L., Matchett, A., and Koski, T. A. (1973) Isolation of porcine parvovirus from commercial trypsin. Appl. Microbiol. 26, 431.

17.	Coffin, J. M. (1992) Structure and classification of retroviruses, in The Retroviridae (Levy, J. A., ed.), Plenum, New York, vol. 1, pp. 19–50.

18.	Silver, J., Maudru, T., Fujita, K., and Repaske, R. (1993) An RT-PCR assay for the enzyme activity of reverse transcriptase capable of detecting single virions. Nucleic Acids Res. 21, 3593–3594.

19.	Armstrong, J. A., Porterfield, J. S., and Teresa de Madrid, A. (1971) C type virus particles in pig kidney cell lines. J. Gen. Virol. 10, 195–198.

20.	Smith, K. T., Shepherd, A. J., Boyd, J. E., and Lees, G. M. (1996) Gene delivery systems for use in gene therapy: an overview of quality assurance and safety issues. Gene Therapy 3, 190–200.

21.	Shepherd, A. J., Boyd, J. E., Hogg, C. E., Aw, D., and James, K. (1992) Susceptibility of human monoclonal antibody producing B cell lines to infection by human immunodeficiency virus. Hum. Antibody Hybridomas 3, 168–176.

22.	Popovic, M., Kalyanaraman, V. S., Reitz, M. S., and Sarngadharan, M. G. (1982) Identification of the RPMI 8226 retrovirus and its dissemination as a significant contaminant in some widely used human and marmoset cell lines. Int. J. Cancer 30, 93–100.

23.	Hooks, J. J. and Gibbs, C. J. (1975) The foamy viruses. Bacteriol. Rev. 39, 169–190.

24.	Peebles, P. T. (1975) An in vitro focus induction assay for xenotropic murine leukaemia virus, feline leukaemia virus C and the feline primate virus RD-114 CCC/M7. Virology 67, 288–291.

25.	Bassin, R. H., Ruscetti, S., Ali, I., Haapala, D. K., and Reins, A. (1982) Normal DBA/2 mouse cells synthesize a glycoprotein which interferes with MCF virus infection. Virology 123, 139–151.

26.	Haapala, D. K., Robey, W. G., Oroszlan, S. D., and Tsai, W. P. (1985) Isolation from cats of an endogenous type C virus with a novel envelope glycoprotein. J. Virol. 53, 827–833.

27.	Bassin, R. H., Tuttle, N., and Fischinger, P. J. (1971) Rapid cell culture assay technique for murine leukaemia virus. Nature 229, 564–566.

28.	Klement, V., Rowe, W. P., Hartley, J. W., and Pugh, W. E. (1969) Mixed culture cytopathogenicity: a new test for growth of murine leukaemia virus in tissue culture. Proc. Natl. Acad. Sci. USA 63, 753–758.

29.	Lander, M. R. and Chattopadhyay, S. K. (1984). A Mus dunni cell line that lacks sequences closely related to endogenous murine leukaemia viruses and can be infected by ecotropic, amphotropic, xenotropic and mink cell focus-forming viruses. J. Virol. 52, 695–698.

30.	Popovic, M., Sarngadharan, M. G., Read, E., and Gallo, R. C. (1984) Detection, isolation and continuous production of cytopathic retroviruses (HTLV III) from patients with AIDS and pre-AIDS. Science 224, 497–500.

31.	Sommerfelt, M. A. and Weiss, R. A. (1990) Receptor interference groups of 20 retroviruses plating on human cells. Virology 176, 58–69.

32.	Weiss, R. A. (1982) Retroviruses produced by hybridomas. N. Engl. J. Med. 307, 1587.

33.	Donahue, R. E., Kessler, S. W., Bodine, D., McDonagh, K., Dunbar, C., Goodman, S., Agricola, B., Byrne, E., Raffeld, M., Moen, R., Bacher, J., Zsebo, K. M., and Niehuia, A. W. (1992) Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 176, 1125–1135.

34.	Bhatt, P. N., Jacoby, R. O., Morse, H. C., III, and New, A. E. (1986) Murine leukaemia viruses, in Methods in Virology, Academic, New York, pp. 349–388.

35.	Chesesbro, B., Britt, W., Evans, L., Wehrly, K., Nishio, J., and Cloyd, M. (1983) Characterization of monoclonal antibodies reactive with murine leukemia viruses: Use in analysis of strains of Friend MCF and Friend ecotropic murine leukemia virus. Virology 127, 134–148.

36.	McIntosh, K. (1990) Diagnostic virology, in Virology, 2nd ed. (Fields, B. N. and Knipe, D. M., eds.), Raven, New York, pp. 411–440.

37.	Schmidt, N. J. (1989) Cell culture procedures for diagnostic virology, in Diagnostic Procedures for Viral, Rickettsial and Chllamydial Infections, 6th ed., (Schmidt, N. J. and Emmons, R. W., eds.), American Public Health Association, Washington, DC, pp. 51–100.

38.	Morgan-Caper, P. and Pattison, J. R. (1985) Techniques in clinical virology, in Virology. A Practical Approach (Mahy, B. W. J., ed.), IRL, Oxford, pp. 237–258.

39.	Animal and Plant Health Inspection Service. United States Department of Agriculture (1995). Code of Federal Regulations 9. Animals and Animal Products. 1995; Part 113. 53. 8. US Government Printing Office, Washington, DC.

40.	Gould, E. A. and Clegg, J. C. S. (1985) Growth, assay and purification of alphaviruses and flaviviruses, in Virology. A Practical Approach (Mahy, B. W. J., ed.), IRL, Oxford, pp. 43–78.

41.	Shepherd, A. J. (1988) Viral hemorrhagic fever: laboratory diagnosis, in Handbook of Viral and Rickettsial Hemorrhagic Fever (Gear, J. H. S., ed.), CRC, Boca Raton, FL, pp. 241–250.

42.	Schmidt, N. J. and Emmons, R. W. (1989) General principles of laboratory diagnostic methods for viral, rickettsial and chlamydial infections, in Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections, 6th ed., (Schmidt, N. J. and Emmons, R. W., eds.), American Public Health Association, Washington, DC, pp. 1–36.

43.	Carthew, P. (1986) Is rodent virus contamination of monoclonal antibody preparations for use in human therapy a hazard? J. Gen. Virol. 67, 963–974.

44.	Mahy, B. W. J., Dykewicz, C., Fisher-Hoch, S., Ostroff, S., Tipple, M., and Sanchez, A. (1991) Virus zoonoses and their potential for contamination of cell cultures. Develop. Biol. Standard 75, 183–189.

Comments (Loading...)

Post comment/View all comments